Alterations of the intestinal microbiota in age-related macular degenerationOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether the gut microbiota differs in people with age-related macular degeneration (AMD), a leading cause of vision loss after age 50. Researchers compared fecal bacteria between AMD patients and healthy controls. They used 16S rRNA gene sequencing of the V3-V4 region on the Illumina MiSeq platform. Sequences were clustered into operational taxonomic units at 97 percent similarity. The team then applied BugBase for phenotype prediction and PICRUSt2 to predict KEGG functional pathways from the bacterial profiles.
Who was studied?
The cohort was 30 patients with advanced AMD and 17 age- and sex-matched healthy controls, all recruited at Shanghai Tenth People's Hospital in China. All participants were over 50 years old. AMD was confirmed by ophthalmic examination including fundoscopy and optical coherence tomography angiography. Controls had no fundus abnormality. Body mass index, hypertension, diabetes, smoking, and drinking history did not differ significantly between the two groups. People with recent antibiotic use or gastrointestinal surgery were excluded.
What were the most important findings?
The AMD gut microbiota was significantly altered. The Simpson diversity index was lower in AMD patients than in controls, and Chao1, observed-species, and Shannon indices also differed between groups. In total 16 phyla and 276 genera were identified. Beta-diversity analysis by PLS-DA showed clear separation between the two groups. BugBase phenotype prediction showed AMD patients had significantly higher relative abundance of stress-tolerant, Gram-negative, and potentially pathogenic bacteria, and lower Gram-positive abundance. PICRUSt2 found 6,507 predicted KEGG orthologs. The top eight orthologs enriched in AMD mapped mainly to lipopolysaccharide biosynthesis.
What are the greatest implications of this study?
The findings suggest AMD is accompanied by gut dysbiosis, with a shift toward Gram-negative, lipopolysaccharide-producing bacteria that could promote systemic inflammation via the proposed gut-retina axis. The authors propose specific bacteria and predicted metabolic pathways as candidate non-invasive markers or treatment targets for AMD. This was a single-center study with a small sample and inferred (not directly measured) functions. It shows association, not causation, so larger multi-center studies and direct metabolite analysis are needed.